Boston Scientific (NYSE:BSX) is trading up 15% on positive trials of one of its products.
IAC/Interactive (NASDAQ:IACI) is trading up 6% on news that CEO Barry Diller won the right in a cout case to break-up the company.
Schering-Plough (NYSE:SGP) is down 19% on negative news on one of its most important drugs.
Thornburg (NYSE:TMA) is off 15% on news that the company is still trying to raise more capital.
Douglas A. McIntyre is an editor at 247wallst.com.










